4//SEC Filing
Langermann Sol 4
Accession 0001123292-21-000493
CIK 0001661059other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:45 PM ET
Size
5.2 KB
Accession
0001123292-21-000493
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Langermann Sol
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-03-15+100,000→ 100,000 totalExercise: $12.59Exp: 2031-03-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on March 15, 2022. The remainder vests in 36 monthly installments beginning on April 15, 2022.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
Related Parties
1- filerCIK 0001775459
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:45 PM ET
- Size
- 5.2 KB